Status:
COMPLETED
Prognostic Value of Sarcopenia and Nutritional Status in Early-stage Non-small Cell Lung Cancer
Lead Sponsor:
Fudan University
Conditions:
Sarcopenia
Non Small Cell Lung Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
Growing evidence has confirmed that the prognosis of lung cancer is not only related to the stage of disease, but also to the physiological and psychological situation of the patients. Malignant tumor...
Detailed Description
The prognosis of lung cancer is not only related to the stage of disease, but also to the physiological and psychological situation of the patients. Malignant tumors are often associated with weakness...
Eligibility Criteria
Inclusion
- The patients with non-small cell lung cancer diagnosed by cytology or pathology meet the standards of clinical diagnosis and treatment guidelines for lung cancer of Chinese Medical Association (2018 Edition)
- TNM staging diagnosis of lung cancer meets the stage IA-IIIA
Exclusion
- Severe heart failure, acute progressive pulmonary inflammation, acute liver and kidney dysfunction in recent 2 weeks
- Incomplete clinical and follow-up data or disagreement or inability to conduct regular follow-up CT imaging evaluation
- A history of other malignant tumors and related tumor chemotherapy within half year, and previous history of radiotherapy
- Unable to walk, fail to complete the walking test, and the risk of fall down
- Unable to complete BIA examination due to pacemaker implantation and other reasons
- Withdraw from the study for any reasons
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
469 Patients enrolled
Trial Details
Trial ID
NCT05212285
Start Date
January 1 2020
End Date
April 30 2025
Last Update
August 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huadong hospital, Fudan University
Shanghai, Shanghai Municipality, China, 200040